Havas Health Network

*Rare Revinar 18 is now available to watch!* https://lnkd.in/eAXwnmNF We're proud to have sponsored the latest Rare Revinar, by RARE Revolution Magazine, on Public-Private Partnerships in #RareDisease. The discussion was facilitated by Nicola Miller, Editor-in-Chief of RARE Revolution Magazine, and features experts Sarah Mikhailov (Managing Director, Havas Life London), Sheela Upadhyaya (Independent Life Sciences Consultant), Eric Litjens, MSc, PhD (Prilenia), Victoria Hedley (Newcastle University), and Nadiah Hanim Abdul Latif (Malaysian Rare Disorders Society). The webinar explores the definition and importance of PPPs in improving services, research, and access to treatments in the rare disease space. At Havas Life London, our role as collaborator and strategic partner enables us to facilitate creative solutions beyond just funding, including education, communication, and technology integration. Watch the full webinar now: https://lnkd.in/eAXwnmNF

Weight loss drugs aren’t just changing bodies—they’re flipping entire industries on their heads. With 1 in 8 adults now on GLP-1s and the market projected to explode to $150 billion by 2033, brands have a shot at reaching a new kind of consumer—one who is eating less, moving more, and rethinking everything from dinner to downtime. As appetite drives a shift in the way people shop, nimble marketers in every category have an opportunity to meet the moment. This #ClioHealth panel with Daily Harvest’s Christina Gutiérrez-Williams, Ugur Kucukcetin and Alexandra Sowa, MD, MA dove i nto the cultural ripple effect of weight loss drugs—and how creative leaders are helping to rebrand, reposition, and redefine what it means to be healthy in 2025.

Yesterday, Brian Robinson, our Global Chief Strategy Officer and GLP-1 Consultancy Lead at Havas Health Network, moderated a powerful discussion on the rise of GLP-1s at the latest Catalyst Conversations event, presented by Clio Health.   The “GLP-1s Disrupting the Advertising Game” panel explored how weight loss drugs are not only changing bodies—they’re transforming industries, consumer habits, and brand strategies across the board.   A huge thank you to Alexandra Sowa, MD, MA, Founder of SoWell and author of The Ozempic Revolution; Christina Gutiérrez-Williams, Director of Culinary R&D at Daily Harvest; and Ugur Kucukcetin, Global Pharma Executive (formerly Novartis & Novo Nordisk), for joining Brian and sharing such valuable insights throughout the conversation!   And a special thanks to #ClioHealth for bringing together some of the brightest minds across health, creativity, and innovation to spark conversations that truly move our industry forward.   #OneHavas #MeaningfulDifference #GLP1s #GLP1Revolution #ClioHealth The Clios

“Neurodivergent thinkers don't just define ideas, they reimagine them. They create what AI never could, the unexpected, the transformative, the future."   We’re incredibly proud of Donna Murphy, Global CEO of Havas Health & Creative Networks, who was honored earlier this week as a Corporate Champion of Neurodivergence by Creative Spirit US. Her leadership brings creativity and innovation together, making Havas a place where different ideas—and people—can thrive.   #OneHavas #MeaningfulDifference #CreativeSpirit #IlluminatingBrilliance

We're calling on all marketers and advertisers—neurodivergent and neurotypical alike—to help shape the future of inclusive workplaces.   Understood.org, a proud partner of Neuroverse: Powered by Havas, is conducting a new study on workplace experiences across our industry. Your insights can help drive real change.   Take a few minutes to share your perspective and be part of the movement ⭐️ https://lnkd.in/eKz_pcUP    #OneHavas #MeaningfulDifference #Neuroverse #Neurodiversity 

Proud to share the news from our global network: Havas is partnering with Ostro, the fastest-growing AI engagement platform in life sciences.   This first-of-its-kind collaboration brings compliant, real-time personalization and next-best-action capabilities to the forefront of healthcare communications, helping us deliver more meaningful connections between brands and patients.   Exciting things are ahead! ⭐️   #OneHavas #MeaningfulDifference

Congratulations, Alma Selles Reilly for being named a #TopDTCMarketeroftheYear! You’re the clear choice. DTC Perspectives Arnold Worldwide #OneHavas #MeaningfulDifference

Congratulations to Wendy Lua for being named a #TopDTCMarketeroftheYear! No one deserves it more than you. And we mean that from the bottom of our ❤️   DTC Perspectives Arnold Worldwide #OneHavas #MeaningfulDifference

World Orphan Drug Congress (WODC) is only a few days away and Havas Life Rare has a special announcement. Our very own Kristin Marvin Keller, Managing Director of Havas Life Rare, will be facilitating a panel discussion on The Science of Patient and Physician Activation. She will be taking the stage with speakers Jody Zschiedrich, Head of Strategy, Havas Life Rare, and Jennifer Siedman, Director of Community Engagement, Courageous Parents Network. Together they will discuss how health literacy and learning models can be harnessed for patient and physician activation to create commercial momentum. Courageous Parents Network #HavasHealth making a #meaningfuldifference #Havas #HavasLifeRare #RareDisease #RareDiseaseAgency #WODC2025 #WorldOrphanDrugUSA

Eric Weisberg, Global Chief Creative Officer at Havas Health Network, joins the latest AW360 podcast to explore the creative revolution transforming health and wellness marketing.   Hear his take on Gen Z’s bold stance on care, how “Welltainment” is breaking stigmas, the potential for innovation in highly regulated spaces, and how health brands are tapping into tech, culture, and creativity to help close the health equity gap.   Listen here: https://lnkd.in/eF-2_m49   #OneHavas #MeaningfulDifference